Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases -WAYNE, Pa., Feb. 12, 2025 ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

Aclaris Therapeutics (ACRS) announced the availability of a new publication describing properties of Aclaris Therapeutics’ ATI-2138, a novel ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

If you struggle with hair loss, you probably have come up with a hundred possible reasons that could be causing it: from ...

MEI Pharma, Inc. (Nasdaq: MEIP) (the "Company") today reported results for its quarter ended December 31, 2024.

Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...

Exelixis reported $515.2M in net product revenues in Q4'24, a 20% increase over net product revenues for Q4'23. See why I ...